Late gadolinium enhancement CMR for detecting myocardial injury after cancer therapy: a real-world observational study - Top-Institutions - MDSpire

Late gadolinium enhancement CMR for detecting myocardial injury after cancer therapy: a real-world observational study

  • By

  • Xi Liu

  • Yue Gao

  • Zhen Wang

  • Wei-Feng Yan

  • Rui Shi

  • Yuan Li

  • Ying-Shi Sun

  • Zhi-Gang Yang

  • May 1, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Massachusetts General Hospital
    Massachusetts General Hospital

    Boston, Massachusetts

    Key Differentiators

    • Cardiology
    • Cardio-Oncology

  • #2

    Brigham and Women’s Hospital
    Brigham and Women’s Hospital

    Boston, Massachusetts

    Key Differentiators

    • Cardiology
    • Cardio-Oncology

  • #3

    Cleveland Clinic
    Cleveland Clinic

    Cleveland, Ohio

    Key Differentiators

    • Cardiology
    • Cardio-Oncology

Original Source(s)

Late gadolinium enhancement CMR for detecting myocardial injury after cancer therapy: a real-world observational study

  • by Xi Liu, Yue Gao, Zhen Wang, Wei-Feng Yan, Rui Shi, Yuan Li, Ying-Shi Sun, Zhi-Gang Yang

  • May 1, 2026

Related Content

Characteristics and risk factors of immune-related adverse events in patients receiving immune checkpoint inhibitor combination therapy

Data requirements of an informative, directive, and preventive mobile health application for gastric cancer

FOXA2 in cancer: from fundamental biology to clinical translation